AOD-9604 and MOTS-C represent two fundamentally different approaches to fat metabolism research. AOD-9604 is a synthetic fragment of human growth hormone designed to isolate the li...
Weight Loss
Research on metabolic and weight-related peptides including GLP-1 receptor agonists, AOD-9604, and Tesamorelin. Covers preclinical studies on appetite regulation, lipolysis, insulin sensitivity, and metabolic pathway modulation.
Semax Peptide Deep Dive: BDNF Modulation and Cognitive Research
Author : Spartan Research Team
Semax peptide deep dive: ACTH-derived mechanism, BDNF upregulation via melanocortin receptors, cognitive research in animal models, neuroprotection in ischemia studies, and compari...
GLP-1 Sema vs GLP-2 Tirz: Research Mechanisms Compared
Author : Spartan Research Team
Two peptide compounds have reshaped metabolic research over the last decade. GLP-1 Sema and GLP-2 Tirz share a common target, the GLP-1 receptor, but they aren’t the same mol...
Skinny Fit Max Research Stack: GLP-3 Reta, MOTS-c and AOD-9604 Metabolic Synergy
Author : Spartan Research Team
Stack: Skinny Fit Max GLP-3(Reta) + MOTS-c + AOD-9604 | Preclinical and early-phase clinical research stack | For laboratory and in vitro research use only Three peptides. Three en...
Understanding the Skinny and Fit Peptide Stack: Multi-Pathway Metabolic Research
Author : Spartan Research Team
Updated May 2026. Understanding the Skinny and Fit peptide stack means tracking the latest preclinical research on all three compounds. This article covers current findings on mult...
Best Peptides for Weight Loss 2026 | Spartan Peptides
Author : Spartan Research Team
Best peptides for weight loss research in 2026. GLP-1(Sema), AOD-9604, MOTS-c and multi-agonists compared on mechanism, receptor targets, and study data.